The FDA has approved Blujepa for the treatment of uncomplicated urogenital gonorrhea caused by susceptible strains of Neisseria gonorrhoeae.

The FDA approved gepotidacin (Blujepa), an oral option for the treatment of uncomplicated urogenital gonorrhea among patients ...

The FDA has cleared the use of GSK’s Blujepa for the treatment of uncomplicated urogenital gonorrhea, unlocking the first new ...

GSK secures FDA approval for its oral gonorrhoea drug as EMA backs expanded RSV vaccine and additional respiratory treatments ...

US FDA approves GSK’s Blujepa as oral option for treatment of uncomplicated urogenital gonorrhoea: London, UK Saturday, December 13, 2025, 09:00 Hrs [IST] GSK plc announced that ...

Discusses SCOPE Phase II Data: iSCIB1+ Shows Improved Progression-Free Survival in Advanced Melanoma December 11, 2025 9:00 ...

London: GSK has announced that the US Food and Drug Administration (FDA) has approved a supplemental New Drug Application for ...

The FDA has approved GSK's gepotidacin (Blujepa), the first new antibiotic class for gonorrhea in over three decades, ...

The WHO has labeled drug-resistant gonorrhea a serious and urgent public health threat. If left untreated, gonorrhea ...

One of the best upgrades you can make to your home office is the addition of a monitor arm. A good-quality arm not only frees up usable space on your desk’s surface, it enables more ways to move and ...

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools.